The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Maiborodin I.V.

Institute of Chemical Biology and Fundamental Medicine;
Novosibirsk Medical and Dental Institute «Dentmaster»

Goncharov M.A.

Institute of Chemical Biology and Fundamental Medicine

Sheplev B.V.

Novosibirsk Medical and Dental Institute «Dentmaster»

Shumeikina A.O.

Research Center for Fundamental and Translational Medicine;
Medical and Diagnostic Center «AvisMed»

Krasil’nikov S.E.

Research Center for Fundamental and Translational Medicine;
Medical and Diagnostic Center «AvisMed»;
Novosibirsk National Research State University

Chernomortseva E.S.

Immanuel Kant Baltic Federal University

Endometrial vascularisation in hyperplasia without atypia

Authors:

Maiborodin I.V., Goncharov M.A., Sheplev B.V., Shumeikina A.O., Krasil’nikov S.E., Chernomortseva E.S.

More about the authors

Read: 1100 times


To cite this article:

Maiborodin IV, Goncharov MA, Sheplev BV, Shumeikina AO, Krasil’nikov SE, Chernomortseva ES. Endometrial vascularisation in hyperplasia without atypia. Russian Journal of Archive of Pathology. 2025;87(6):28‑33. (In Russ.)
https://doi.org/10.17116/patol20258706128

Recommended articles:
Use of gona­dotropic releasing hormone agonists in hype­rplastic syndrome in gyne­cology. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):51-58
Influence of limb reva­scularization and therapeutic angiogenesis on concentration of angiogenic factors. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):539-546
The possibilities of realizing reproductive function in women with endo­metrial hype­rplasia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):98-105

References:

  1. Mori H, Nishida H, Kusaba T, et al. Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary. Medicine (Baltimore). 2023;102(37):e35301. https://doi.org/10.1097/MD.0000000000035301
  2. Wang XX, Hua T, Wang HB. Estrogen receptor-related receptor γ uppresses hypoxia-induced angiogenesis by regulating VEGFA in endometrial cancer. Gynecol Endocrinol. 2023;39(1):2264411. https://doi.org/10.1080/09513590.2023.2264411
  3. Yoshino O, Ono Y. The physiological role of macrophages in reproductive organs. Reprod Med Biol. 2025;24(1):e12637. https://doi.org/10.1002/rmb2.12637
  4. Yetkin-Arik B, Kastelein AW, Klaassen I, et al. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188446. https://doi.org/10.1016/j.bbcan.2020.188446
  5. Maiborodin IV, Goncharov MA, Shevela AI, et al. Angiogenesis in endometrial cancer: clinical and biological significance. Siberian Journal of Oncology. 2024;23(4):172-185. (In Russ.). https://doi.org/10.21294/1814-4861-2024-23-4-172-185
  6. Ozalp S, Yalcin OT, Acikalin M, et al. Microvessel density (MVD) as a prognosticator in endometrial carcinoma. Eur J Gynaecol Oncol. 2003;24(3-4):305-308. 
  7. Guşet G, Costi S, Lazăr E, et al. Expression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinoma. Rom J Morphol Embryol. 2010;51(4):677-682. 
  8. Kilinç E, Bahar AY. The Value of Intratumoral and Extratumoral Microvessel Density for the Tumor-dominated Area in the Endometrial Carcinoma. Appl Immunohistochem Mol Morphol. 2022;30(7):501-508.  https://doi.org/10.1097/PAI.0000000000001044
  9. Drocaş I, Crăiţoiu Ş, Stepan AE, et al. The analysis of hormonal status and vascular and cell proliferation in endometrioid endometrial adenocarcinomas. Rom J Morphol Embryol. 2022;63(1):113-120.  https://doi.org/10.47162/RJME.63.1.11
  10. Kaku T, Kamura T, Kinukawa N, et al. Angiogenesis in endometrial carcinoma. Cancer. 1997;80(4):741-747.  https://doi.org/10.1002/(sici)1097-0142(19970815)80:4<741::aid-cncr13>3.0.co;2-t
  11. Bhosale NM, Arakeri SU, Reddy AK, Mudanur SR. Endometrial blood vessel morphometry in patients presenting with abnormal uterine bleeding. Indian J Pathol Microbiol. 2022;65(4):844-850.  https://doi.org/10.4103/ijpm.ijpm_89_21
  12. Kaku T, Hirakawa T, Kamura T, et al. Angiogenesis in adenocarcinoma of the uterine cervix. Cancer. 1998;83(7):1384-1390. https://doi.org/10.1002/(sici)1097-0142(19981001)83:7<1384::aid-cncr16>3.0.co;2-0
  13. Erdem O, Erdem M, Erdem A, et al. Expression of vascular endothelial growth factor and assessment of microvascular density with CD 34 and endoglin in proliferative endometrium, endometrial hyperplasia, and endometrial carcinoma. Int J Gynecol Cancer. 2007;17(6):1327-1332. https://doi.org/10.1111/j.1525-1438.2007.00942.x
  14. Abulafia O, Triest WE, Sherer DM, et al. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol. 1995;86(4 Pt 1):479-485.  https://doi.org/10.1016/0029-7844(95)00203-4
  15. Maiborodin IV, Kozjakov AE, Babayants EV, Krasilnikov SE. Angiogenesis in Lymph Nodes in the Development of Cancer in the Region of Lymph Collection. Novosti Khirurgii. 2016;24(6):579-585. (In Russ.). https://doi.org/10.18484/2305-0047.2016.6.579
  16. Makhija D, Mathai AM, Naik R, et al. Morphometric evaluation of endometrial blood vessels. Indian J Pathol Microbiol. 2008;51(3):346-350.  https://doi.org/10.4103/0377-4929.42508
  17. Kataria SP, Arora S, Kumar S, et al. Microvessel density assessment using CD105 (Endoglin) in cyclic endometrium, endometrium hyperplasia and carcinoma. International J. of Healthcare and Biomedical Research. 2021;9(2):5-17. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.